Ionis Pharmaceuticals (IONS) Finished Goods (2018 - 2025)
Ionis Pharmaceuticals (IONS) posted quarterly Finished Goods of $2.1 million for Q1 2025, up 959.0% year-over-year from $200000.0 in Q1 2024, and up 667.39% quarter-over-quarter from $276000.0 in Q4 2024.
Powered by 
Analysis
Ionis Pharmaceuticals (IONS) Finished Goods (2018 - 2025) Analysis & Trends
Ionis Pharmaceuticals' Finished Goods history runs 8 years deep, the most recent figure standing at $2.1 million for Q1 2025.
- In Q1 2025, Finished Goods rose 959.0% year-over-year to $2.1 million; the TTM figure through Mar 2025 stood at $2.1 million (up 959.0% YoY), while the FY2024 annual figure was $276000.0, up 79.22% from the prior year.
- Finished Goods for Q1 2025 stood at $2.1 million, up from $276000.0 in the prior quarter.
- The five-year high for Finished Goods was $2.1 million in Q1 2025, with the low at $63000.0 in Q3 2024.
- The 5-year median for Finished Goods is $288000.0 (2022), against an average of $563294.1.
- The sharpest annual moves came in 2021 and 2025: Finished Goods plunged 87.02% in 2021, then soared 959.0% in 2025.
- Ionis Pharmaceuticals' Finished Goods stood at $390000.0 in 2021, then tumbled by 57.95% to $164000.0 in 2022, then retreated by 6.1% to $154000.0 in 2023, then jumped by 79.22% to $276000.0 in 2024, then jumped by 667.39% to $2.1 million in 2025.
- Business Quant data shows IONS's Finished Goods at $2.1 million in Q1 2025, $276000.0 in Q4 2024, and $63000.0 in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Ionis Pharmaceuticals | 9.60 Bn | 7.55 Bn | 265.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 2.12 Mn |
| Dec 31, 2024 | 276,000.00 |
| Sep 30, 2024 | 63,000.00 |
| Jun 30, 2024 | 486,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Dec 31, 2023 | 154,000.00 |
| Sep 30, 2023 | 176,000.00 |
| Jun 30, 2023 | 196,000.00 |
| Mar 31, 2023 | 218,000.00 |
| Dec 31, 2022 | 164,000.00 |
| Sep 30, 2022 | 288,000.00 |
| Jun 30, 2022 | 309,000.00 |
| Mar 31, 2022 | 466,000.00 |
| Dec 31, 2021 | 390,000.00 |
| Sep 30, 2021 | 607,000.00 |
| Jun 30, 2021 | 1.56 Mn |
| Mar 31, 2021 | 1.91 Mn |
| Dec 31, 2020 | 3.01 Mn |
| Sep 30, 2020 | 950,000.00 |
| Jun 30, 2020 | 741,000.00 |